Your browser doesn't support javascript.
loading
Presence of hypervirulence-associated determinants in Klebsiella pneumoniae from hospitalised patients in Germany.
Wahl, Anika; Fischer, Martin A; Klaper, Kathleen; Müller, Annelie; Borgmann, Stefan; Friesen, Johannes; Hunfeld, Klaus-Peter; Ilmberger, Arkadius; Kolbe-Busch, Susanne; Kresken, Michael; Lippmann, Norman; Lübbert, Christoph; Marschner, Matthias; Neumann, Bernd; Pfennigwerth, Niels; Probst-Kepper, Michael; Rödel, Jürgen; Schulze, Marco H; Zautner, Andreas E; Werner, Guido; Pfeifer, Yvonne.
Affiliation
  • Wahl A; Robert Koch Institute, Division of Infectious Diseases, Department of Nosocomial Pathogens and Antibiotic Resistances, Wernigerode, Germany.
  • Fischer MA; Robert Koch Institute, Division of Infectious Diseases, Department of Nosocomial Pathogens and Antibiotic Resistances, Wernigerode, Germany.
  • Klaper K; Robert Koch Institute, Department of Sexually transmitted bacterial Pathogens (STI) and HIV, Berlin, Germany.
  • Müller A; Robert Koch Institute, Division of Infectious Diseases, Department of Nosocomial Pathogens and Antibiotic Resistances, Wernigerode, Germany.
  • Borgmann S; Klinikum Ingolstadt, Department of Infectious Diseases and Infection Control, Ingolstadt, Germany.
  • Friesen J; MVZ LABOR 28 GMBH, Berlin, Germany.
  • Hunfeld KP; Institute for Laboratory Medicine, Microbiology & Infection Control, Northwest Medical Centre, Medical Faculty, Goethe University, Frankfurt am Main, Germany.
  • Ilmberger A; Labor MVZ Westmecklenburg, Schwerin, Germany.
  • Kolbe-Busch S; Institute of Hygiene, Hospital Epidemiology and Environmental Medicine, Leipzig University Medical Center, Leipzig, Germany; Interdisciplinary Center for Infectious Diseases, Leipzig University Medical Center, Leipzig, Germany.
  • Kresken M; Paul-Ehrlich-Gesellschaft für Infektionstherapie e. V., Cologne, Germany.
  • Lippmann N; Institute for Medical Microbiology and Virology, University Hospital of Leipzig, Leipzig, Germany.
  • Lübbert C; Interdisciplinary Center for Infectious Diseases, Leipzig University Medical Center, Leipzig, Germany; Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Leipzig University Medical Center, Leipzig, Germany.
  • Marschner M; Sankt Gertrauden-Krankenhaus GmbH, Berlin, Germany.
  • Neumann B; Institute of Clinical Microbiology, Infectious Diseases and Infection Control, Paracelsus Medical University, Nuremberg General Hospital, Nuremberg, Germany.
  • Pfennigwerth N; German National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
  • Probst-Kepper M; MVZ Diamedis Sennestadt GmbH, Bielefeld, Germany.
  • Rödel J; Institute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
  • Schulze MH; Department for Infection Control and Infectious Diseases, University Medical Center Goettingen, Goettingen, Germany.
  • Zautner AE; Institute of Medical Microbiology and Hospital Hygiene, Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany; Center for Health and Medical Prevention (CHaMP), Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
  • Werner G; Robert Koch Institute, Division of Infectious Diseases, Department of Nosocomial Pathogens and Antibiotic Resistances, Wernigerode, Germany.
  • Pfeifer Y; Robert Koch Institute, Division of Infectious Diseases, Department of Nosocomial Pathogens and Antibiotic Resistances, Wernigerode, Germany. Electronic address: pfeifery@rki.de.
Int J Med Microbiol ; 314: 151601, 2024 Mar.
Article de En | MEDLINE | ID: mdl-38359735
ABSTRACT

BACKGROUND:

Klebsiella (K.) pneumoniae is a ubiquitous Gram-negative bacterium and a common coloniser of animals and humans. Today, K. pneumoniae is one of the most persistent nosocomial pathogens worldwide and poses a severe threat/burden to public health by causing urinary tract infections, pneumonia and bloodstream infections. Infections mainly affect immunocompromised individuals and hospitalised patients. In recent years, a new type of K. pneumoniae has emerged associated with community-acquired infections such as pyogenic liver abscess in otherwise healthy individuals and is therefore termed hypervirulent K. pneumoniae (hvKp). The aim of this study was the characterisation of K. pneumoniae isolates with properties of hypervirulence from Germany.

METHODS:

A set of 62 potentially hypervirulent K. pneumoniae isolates from human patients was compiled. Inclusion criteria were the presence of at least one determinant that has been previously associated with hypervirulence (I) clinical manifestation, (II) a positive string test as a marker for hypermucoviscosity, and (III) presence of virulence associated genes rmpA and/or rmpA2 and/or magA. Phenotypic characterisation of the isolates included antimicrobial resistance testing by broth microdilution. Whole genome sequencing (WGS) was performed using Illumina® MiSeq/NextSeq to investigate the genetic repertoire such as multi-locus sequence types (ST), capsule types (K), further virulence associated genes and resistance genes of the collected isolates. For selected isolates long-read sequencing was applied and plasmid sequences with resistance and virulence determinants were compared.

RESULTS:

WGS analyses confirmed presence of several signature genes for hvKp. Among them, the most prevalent were the siderophore loci iuc and ybt and the capsule regulator genes rmpA and rmpA2. The most dominant ST among the hvKp isolates were ST395 capsule type K2 and ST395 capsule type K5; both have been described previously and were confirmed by our data as multidrug-resistant (MDR) isolates. ST23 capsule type K1 was the second most abundant ST in this study; this ST has been described as commonly associated with hypervirulence. In general, resistance to beta-lactams caused by the production of extended-spectrum beta-lactamases (ESBL) and carbapenemases was observed frequently in our isolates, confirming the threatening rise of MDR-hvKp strains.

CONCLUSIONS:

Our study results show that K. pneumoniae strains that carry several determinants of hypervirulence are present for many years in Germany. The detection of carbapenemase genes and hypervirulence associated genes on the same plasmid is highly problematic and requires intensified screening and molecular surveillance. However, the non-uniform definition of hvKp complicates their detection. Testing for hypermucoviscosity alone is not specific enough to identify hvKp. Thus, we suggest that the classification of hvKp should be applied to isolates that not only fulfil phenotypical criteria (severe clinical manifestations, hypermucoviscosity) but also (I) the presence of at least two virulence loci e.g. iuc and ybt, and (II) the presence of rmpA and/or rmpA2.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à Klebsiella / Infections communautaires Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Int J Med Microbiol Sujet du journal: MICROBIOLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à Klebsiella / Infections communautaires Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Int J Med Microbiol Sujet du journal: MICROBIOLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Allemagne